IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pivotal bioVenture Partners Investment Advisor LLC

Q4 2020 Holdings

Filed 2021-02-09 | 9 holdings | $19.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$18.9M671,71698.5%
Karuna Therapeutics IncCOM48576A100$110.1K1,083,3440.6%
Vaxcyte Inc(PCVX)COM92243G108$59.1K2,222,9700.3%
Akouos IncCOM00973J101$35.6K1,794,0880.2%
Inozyme Pharma IncCOM45790W108$32.8K1,591,1540.2%
Aligos Therapeutics IncCOM01626L105$24.2K876,5480.1%
Fusion Pharmaceuticals IncCOM36118A100$18.8K1,598,3790.1%
Entasis Therapeutics Hldgs ICOM293614103$2.9K1,180,1780.0%
Iterum Therapeutics PLCSHSG6333L101$935945,0850.0%